Infections after living donor liver transplantation in children

Journal of Korean Medical Science

Volumn 25, Issue 4, 2010, Pages 527-531

  Kim, Jeong Eun ^a,b   Oh, Seak Hee ^a   Kim, Kyung Mo ^a   Choi, Bo Hwa ^a,c   Kim, Dae Yeon ^a   Cho, Hyung Rae ^a   Lee, Yeoun Joo ^a   Rhee, Kang Won ^a   Park, Seong Jong ^a   Lee, Young Joo ^a   Lee, Sung Gyu ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Jung gu Community Mental Health Center   (South Korea)

^c Department of Pediatrics   (South Korea)

Author keywords

Child; Infection; Liver transplantation; Living donors

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CHILD; COMMUNICABLE DISEASE; FEMALE; HUMAN; INFECTION; LIVER TRANSPLANTATION; LIVING DONOR; MALE; MICROBIOLOGY; MORTALITY; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; VIROLOGY;

ADULT; CHILD; COMMUNICABLE DISEASES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFECTION; LIVER TRANSPLANTATION; LIVING DONORS; MALE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 77953976722     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.4.527     Document Type: Article

References (23)

1. Shepherd RW, Turmelle Y, Nadler M, Lowell JA, Narkewicz MR, McDiarmid SV, Anand R, Song C. Risk factors for rejection and infection in pediatric liver transplantation. Am J Transplant 2008; 8: 396-403.
2. Alonso EM, Gonzalez-Vallina R, Whitington PF. Update of pediatric liver transplantation. Eur J Pediatr 1992; 151 (Suppl 1): S23-31.
3. Torbenson M, Wang J, Nichols L, Jain A, Fung J, Nalesnik MA. Causes of death in autopsied liver transplantation patients. Mod Pathol 1998; 11: 37-46.
4. Paya CV, Hermans PE, Wiesner RH, Ludwig J, Smith TF, Rakela J, Krom RA. Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations. J Infect Dis 1989; 160: 752-8.
5. Walker RC, Marshall WF, Strickler JG, Wiesner RH, Velosa JA, Habermann TM, McGregor CG, Paya CV. Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis 1995; 20: 1346-53.
6. George DL, Arnow PM, Fox A, Thistlethwaite JR, Emond JC, Broelsch CE, Whitington PF. Patterns of infection after pediatric liver transplantation. Am J Dis Child 1992; 146: 924-9.
7. George DL, Arnow PM, Fox AS, Baker AL, Thistlethwaite JR, Emond JC, Whitington PF, Broelsch CE. Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. Rev Infect Dis 1991; 13: 387-96.
8. Singh N. Infections in solid-organ transplant recipients. Am J Infect Control 1997; 25: 409-17.
9. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338: 1741-51.
10. Raia S, Nery JR, Mies S. Liver transplantation from live donors. Lancet 1989; 2: 497.
11. Hwang S, Lee SG, Lee YJ, Sung KB, Park KM, Kim KH, Ahn CS, Moon DB, Hwang GS, Kim KM, Ha TY, Kim DS, Jung JP, Song GW. Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe. Liver Transplantation 2006; 12: 920-7.
12. Austin MT, Feurer ID, Chari RS, Gorden DL, Wright JK, Pinson CW. Survival after pediatric liver transplantation: why does living donation offer an advantage? Arch Surg 2005; 140: 465-70.
13. Lee SG, Lee YJ, Park KM, Kwon TW, Choi KM, Ha HS, Kim KM, Kim SC, Kim IK, Kim SK, Han SH, Koh KS, Min PC. Living related donor liver transplantation: the Seoul experience. Transplant Proc 1996; 28: 2383-4.
14. Bouchut JC, Stamm D, Boillot O, Lepape A, Floret D. Postoperative infectious complications in paediatric liver transplantation: a study of 48 transplants. Paediatr Anaesth 2001; 11: 93-8.
15. Winston DJ, Emmanouilides C, Busuttil RW. Infections in liver transplant recipients. Clin Infect Dis 1995; 21: 1077-89.
16. Poddar U, Thapa BR, Prasad A, Sharma AK, Singh K. Natural history and risk factors in fulminant hepatic failure. Arch Dis Child 2002; 87: 54-6.
17. Garcia S, Roque J, Ruza F, Gonzalez M, Madero R, Alvarado F, Herruzo R. Infection and associated risk factors in the immediate postoperative period of pediatric liver transplantation: a study of 176 transplants. Clin Transplant 1998; 12: 190-7.
18. Patel R, Paya CV. Infections in solid-organ transplant recipients. Clin Microbiol Rev 1997; 10: 86-124.
19. Patel R, Snydman DR, Rubin RH, Ho M, Pescovitz M, Martin M, Paya CV. Cytomegalovirus prophylaxis in solid organ transplant recipients. Transplantation 1996; 61: 1279-89.
20. Bubak ME, Porayko MK, Krom RA, Wiesner RH. Complications of liver biopsy in liver transplant patients: increased sepsis associated with choledochojejunostomy. Hepatology 1991; 14: 1063-5.
21. Brayman KL, Stephanian E, Matas AJ, Schmidt W, Payne WD, Sutherland DE, Gores PF, Najarian JS, Dunn DL. Analysis of infectious complications occurring after solid-organ transplantation. Arch Surg 1992; 127: 38-47.
22. Engelhard D, Geller N, Paterson DL. Gram-positive and Gram-negative infections after hemopoietic stem cell or solid organ transplantation. In: Bowden RA, Ljungman P, Paya CV, eds, Transplant infections 2nd ed. London: Lippincott Williams & Wilkins 2003; 237-9.
23. Lee TC, Savoldo B, Rooney CM, Heslop HE, Gee AP, Caldwell Y, Barshes NR, Scott JD, Bristow LJ, O'Mahony CA, Goss JA. Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients. Am J Transplant 2005; 5: 2222-8.